Martin Charles Faulkes - Jul 14, 2021 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role: Director
Signature: /s/ Martin Charles Faulkes
Stock symbol: VNRX
Transactions as of: Jul 14, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/16/2021, 05:00 PM
Next filing: Sep 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNRX	Stock Option (Right to Buy)	Disposed to Issuer		-40K	-100%		0	Jul 14, 2021	Common Stock	40K	$4.00	Direct	F1
transaction	VNRX	Stock Option (Right to Buy)	Award		+40K			40K	Jul 14, 2021	Common Stock	40K	$4.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).

Content

The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).